Treatment of anxiety disorders in the Finnish general population

Journal of Affective Disorders

Volumn 96, Issue 1-2, 2006, Pages 31-38

  Sihvo, Sinikka ^a   Hämäläinen, Juha ^a,b   Kiviruusu, Olli ^a   Pirkola, Sami ^a   Isometsä, Erkki ^a,c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Eastern Health Centre   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antidepressants; Anxiety disorders; Anxiolytics; Population based survey; Psychotropics

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FINLAND; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MENTAL HEALTH SERVICE; MOOD DISORDER; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOPHARMACOTHERAPY; SAMPLE; SELF REPORT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COMORBIDITY; FAMILY PRACTICE; FEMALE; FINLAND; GUIDELINE ADHERENCE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; MOOD DISORDERS; POPULATION SURVEILLANCE; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRY; PSYCHOTHERAPY; SOCIOECONOMIC FACTORS;

EID: 33750022254     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.05.009     Document Type: Article

References (22)

1. American Psychiatric Association (APA). Practice guidelines for the treatment of patients with panic disorder. Am. J. Psychiatry 155 suppl 5 (1998) 1-34
2. American Psychiatric Association (APA). Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder (2004). http://www.psych.org http://www.psych.org. accessed 4.5.2006
3. Aromaa A., and Koskinen S. Health and functional capacity in Finland. Baseline results of the Health 2000 Health Examination Survey. Publications of the National Public Health Institute B12/2004. Helsinki (2004). http://www.ktl.fi/terveys2000/index.uk.html [Printable from: http://www.ktl.fi/terveys2000/index.uk.html]
4. Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Borkovec T.D., Rickels K., Stein D.J., and Wittchen H.-U. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J. Clin. Psychiatry 62 suppl 11 (2001) 53-58
5. Balwin D.S., Anderson I.M., Nutt D.J., Bandelow B., Davidson J.R.T., den Boer J.A., Fineberg N.A., Knapp M., Scott J., and Wittchen H.-U. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 19 (2005) 567-596
6. de Graaf R., Bijl R.V., Smit F., Vollebergh W.A.M., and Spiker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am. J. Psychiatry 159 (2002) 620-629
7. Duodecim, and Finnish Medical Association Duodecim and Academy of Finland. Panic disorder-consensus statement. Duodecim 116 (2000) 2534-2541 (in Finnish)
8. Issakidis C., and Andrews G. Service utilisation for anxiety in an Australian community sample. Soc. Psychiatry Psychiatr. Epidemiol. 37 (2002) 153-163
9. O'Hayon M., and Lader M.H. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J. Clin. Psychiatry 63 (2002) 817-825
10. Olfson M., Marcus S.C., Wan G.J., and Geissler E.C. National trends in the outpatient treatment of anxiety disorders. J. Clin. Psychiatry 65 (2004) 1166-1173
11. National Institute for Clinical Excellence (NICE). Anxiety. Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. Clin. Guideline 22 (2004). http://www.nice.org.uk (December. [www.nice.org.uk])
12. National Institute for Clinical Excellence (NICE). Post-traumatic stress disorder (NICE). Clin. Guideline 26 (2005). http://www.nice.org.uk (March. [www.nice.org.uk])
13. National Institute for Clinical Excellence (NICE). Obsessive-compulsive disorder. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder (2005). http://www.nice.org.uk November 2005. [www.nice.org.uk]
14. Pirkola S., Isometsä E., Suvisaari J., Aro H., Joukamaa M., Poikolainen K., Koskinen S., Aromaa A., and Lönnqvist J.K. DSM-IV mood-, anxiety-, alcohol use disorders and their comorbidity in the Finnish adult population. Results from the Health 2000 Study. Soc. Psychiatry Psychiatr. Epidemiol. 40 (2005) 1-10
15. The ESEMed/MHEDEA 2000 investigators. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrfs. Scand. 109 supp 420 (2004) 21-27
16. The ESEMed/MHEDEA 2000 investigators. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr. Scand. 109 supp 420 (2004) 55-64
17. The ESEMed/MHEDEA 2000 investigators. Use of mental services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr. Scand. 109 supp 420 (2004) 47-54
18. The WHO World Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organisation World Mental Health Surveys. J. Am. Med. Assoc. 291 (2004) 2581-2590
19. Wang P.S., Lane M., Olfson M., Pincus H.A., Wells K.B., and Kessler R.C. Twelve-month use of mental health services in the United States. Arch. Gen. Psychiatry 62 (2005) 629-640
20. Wittchen H.-U., and Jacobi F. Size and burden of mental disorders in Europe-a critical review and appraisal of 27 studies. Eur. Neuropsychopharmacol. 15 (2005) 357-376
21. Wittchen H.-U., Lachner G., Wunderlich U., and Pfister H. Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc. Psychiatry Psychiatr. Epidemiol. 33 (1998) 568-578
22. Young A.S., Klap R., Sherbourne C.D., and Wells K.B. The quality of care for depressive and anxiety disorders in the United States. Arch. Gen. Psychiatry 58 (2001) 55-61